These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15853688)

  • 21. The role of prostanoids in the development of diabetic embryopathy.
    Wiznitzer A; Furman B; Mazor M; Reece EA
    Semin Reprod Endocrinol; 1999; 17(2):175-81. PubMed ID: 10528368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway.
    González E; Roselló-Catafau J; Jawerbaum A; Vela J; Sinner D; Pustovrh C; White V; Xaus C; Peralta C; Gimeno MA
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):311-6. PubMed ID: 11427040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid.
    Wentzel P; Eriksson UJ
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):506-11. PubMed ID: 15959876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose metabolism in pregnancy and embryogenesis.
    Doblado M; Moley KH
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):488-93. PubMed ID: 17982357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
    Ornoy A
    Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos.
    Eriksson UJ; Borg LA
    Diabetes; 1993 Mar; 42(3):411-9. PubMed ID: 8432412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease.
    Basu M; Zhu JY; LaHaye S; Majumdar U; Jiao K; Han Z; Garg V
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotoxicity and fetal abnormality in streptozotocin-induced diabetic rats exposed to cigarette smoke prior to and during pregnancy.
    Damasceno DC; Volpato GT; Sinzato YK; Lima PH; Souza MS; Iessi IL; Kiss AC; Takaku M; Rudge MV; Calderon IM
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):549-53. PubMed ID: 21667441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling pathways and diabetic embryopathy.
    Dhanasekaran N; Wu YK; Reece EA
    Semin Reprod Endocrinol; 1999; 17(2):167-74. PubMed ID: 10528367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effect on maternal metabolism and fetal outcome.
    Eriksson UJ; Bone AJ; Turnbull DM; Baird JD
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):800-10. PubMed ID: 2658457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of diabetes-induced congenital malformations.
    Eriksson UJ; Borg LA; Cederberg J; Nordstrand H; Simán CM; Wentzel C; Wentzel P
    Ups J Med Sci; 2000; 105(2):53-84. PubMed ID: 11095105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model.
    Shivananjappa MM; Muralidhara
    Reprod Biomed Online; 2012 May; 24(5):558-66. PubMed ID: 22414371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arachidonic acid and cell signalling in the ovary and placenta.
    Boone DL; Currie WD; Leung PC
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):79-87. PubMed ID: 8424126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models in diabetes and pregnancy.
    Jawerbaum A; White V
    Endocr Rev; 2010 Oct; 31(5):680-701. PubMed ID: 20534704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats.
    Reece EA; Wu YK; Zhao Z; Dhanasekaran D
    Am J Obstet Gynecol; 2006 Feb; 194(2):580-5. PubMed ID: 16458664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes.
    Ornoy A; Reece EA; Pavlinkova G; Kappen C; Miller RK
    Birth Defects Res C Embryo Today; 2015 Mar; 105(1):53-72. PubMed ID: 25783684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How and why does the metabolic equilibrium of the mother affect the embryo?].
    Fontaine P
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S13-8. PubMed ID: 11787431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short and long-term repercussions of the experimental diabetes in embryofetal development.
    Bueno A; Sinzato YK; Sudano MJ; Alvarenga Fda C; Calderon Ide M; Rudge MV; Damasceno DC
    Diabetes Metab Res Rev; 2014 Oct; 30(7):575-81. PubMed ID: 24408841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic interactions of diabetes and pregnancy.
    Buchanan TA; Kitzmiller JL
    Annu Rev Med; 1994; 45():245-60. PubMed ID: 8198381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The infant of the diabetic mother: The critical developmental windows.
    Carrapato MR; Marcelino F
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):57-8. PubMed ID: 11753515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.